跳至主要内容
临床试验/JPRN-UMIN000030857
JPRN-UMIN000030857已完成未知

Exploratory study on effectiveness and safety of long-term administration of Rikkunshito for improvement of anorexia and quality of life in patients with Parkinson's disease accompanied by apathy. - Exploratory study on effectiveness and safety of long-term administration of Rikkunshito for improvement of anorexia and quality of life in patients with Parkinson's disease accompanied by apathy.

Saitama Medical Center, Saitama Medical University0 个研究点目标入组 30 人开始时间: 2018年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients applicable to any one of the following items are excluded. (1) Patients complicated of dementia (patients with MoCA-J of 25 or less) (2) Patients with depression, psychiatric symptoms (3) Patients with abnormalities judged to require treatment by brain MRI (performed within 6 months) (4) Patients who can not orally administer (5) Patients who took herbal medicine within the first month before the start of the study (6) Patients who can not discontinue combination use prohibited medicine during the observation period from two weeks before the start of the study (7) Patients complicated of serious complications (heart, liver, kidney function disorder, hematopoietic disorder, malignant tumor etc.) or other diseases judged to affect life (8) Patients allergic to traditional Chinese medicine (9) Patients judged unsuitable by research researcher or research sharing doctor However, MoCA-J of (1) is carried out twice at intervals of 4 weeks, and patients who were 25 points or less at once are excluded.

研究者

发起方
Saitama Medical Center, Saitama Medical University

相似试验